Triazole compounds useful in treating diseases associated with unwanted cytokine activity

本发明涉及下式的4-芳基三唑:式(Ⅰ)其中每个R1独立地选自低级烷基、低级链烯基、低级炔基、低级杂烷基、低级杂烯基、低级杂炔基、杂环烷基、杂芳基、卤素、CN、OR4、SR4、S(O)R4、S(O)2R4和NR4R5;并且Q具有下式(Ⅱ):所述化合物能用于治疗与过度的细胞因子活性,尤其是与例如来自细胞的白介素-1(IL-1)和肿瘤坏死因子(TNF)有关的疾病。 The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VAN RENS JOHN CHARLES, NATCHUS MICHAEL GEORGE, BLASS BENJAMIN ERIC, TULLIS JOSHUA SPECTOR, DE BISWANATH, CLARK MICHAEL PHILIP
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VAN RENS JOHN CHARLES
NATCHUS MICHAEL GEORGE
BLASS BENJAMIN ERIC
TULLIS JOSHUA SPECTOR
DE BISWANATH
CLARK MICHAEL PHILIP
description 本发明涉及下式的4-芳基三唑:式(Ⅰ)其中每个R1独立地选自低级烷基、低级链烯基、低级炔基、低级杂烷基、低级杂烯基、低级杂炔基、杂环烷基、杂芳基、卤素、CN、OR4、SR4、S(O)R4、S(O)2R4和NR4R5;并且Q具有下式(Ⅱ):所述化合物能用于治疗与过度的细胞因子活性,尤其是与例如来自细胞的白介素-1(IL-1)和肿瘤坏死因子(TNF)有关的疾病。 The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1505625A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1505625A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1505625A3</originalsourceid><addsrcrecordid>eNqFyj0KwkAQQOE0FqKewbmA4A9rL0GxskpjFYbdiQ6us0tm1hBPL4K91eODN62uTc_4TpHAp2dORYJCUepKBBawntBYbhBYCZUUUDV5RqMAA9sdigwoX_nR0oOFAL3xi22cV5MOo9Li11m1PB2b-ryinFrSjJ6ErK0vG7d2-6077P4fH46jOv0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Triazole compounds useful in treating diseases associated with unwanted cytokine activity</title><source>esp@cenet</source><creator>VAN RENS JOHN CHARLES ; NATCHUS MICHAEL GEORGE ; BLASS BENJAMIN ERIC ; TULLIS JOSHUA SPECTOR ; DE BISWANATH ; CLARK MICHAEL PHILIP</creator><creatorcontrib>VAN RENS JOHN CHARLES ; NATCHUS MICHAEL GEORGE ; BLASS BENJAMIN ERIC ; TULLIS JOSHUA SPECTOR ; DE BISWANATH ; CLARK MICHAEL PHILIP</creatorcontrib><description>本发明涉及下式的4-芳基三唑:式(Ⅰ)其中每个R1独立地选自低级烷基、低级链烯基、低级炔基、低级杂烷基、低级杂烯基、低级杂炔基、杂环烷基、杂芳基、卤素、CN、OR4、SR4、S(O)R4、S(O)2R4和NR4R5;并且Q具有下式(Ⅱ):所述化合物能用于治疗与过度的细胞因子活性,尤其是与例如来自细胞的白介素-1(IL-1)和肿瘤坏死因子(TNF)有关的疾病。 The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.</description><edition>7</edition><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040616&amp;DB=EPODOC&amp;CC=CN&amp;NR=1505625A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040616&amp;DB=EPODOC&amp;CC=CN&amp;NR=1505625A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VAN RENS JOHN CHARLES</creatorcontrib><creatorcontrib>NATCHUS MICHAEL GEORGE</creatorcontrib><creatorcontrib>BLASS BENJAMIN ERIC</creatorcontrib><creatorcontrib>TULLIS JOSHUA SPECTOR</creatorcontrib><creatorcontrib>DE BISWANATH</creatorcontrib><creatorcontrib>CLARK MICHAEL PHILIP</creatorcontrib><title>Triazole compounds useful in treating diseases associated with unwanted cytokine activity</title><description>本发明涉及下式的4-芳基三唑:式(Ⅰ)其中每个R1独立地选自低级烷基、低级链烯基、低级炔基、低级杂烷基、低级杂烯基、低级杂炔基、杂环烷基、杂芳基、卤素、CN、OR4、SR4、S(O)R4、S(O)2R4和NR4R5;并且Q具有下式(Ⅱ):所述化合物能用于治疗与过度的细胞因子活性,尤其是与例如来自细胞的白介素-1(IL-1)和肿瘤坏死因子(TNF)有关的疾病。 The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyj0KwkAQQOE0FqKewbmA4A9rL0GxskpjFYbdiQ6us0tm1hBPL4K91eODN62uTc_4TpHAp2dORYJCUepKBBawntBYbhBYCZUUUDV5RqMAA9sdigwoX_nR0oOFAL3xi22cV5MOo9Li11m1PB2b-ryinFrSjJ6ErK0vG7d2-6077P4fH46jOv0</recordid><startdate>20040616</startdate><enddate>20040616</enddate><creator>VAN RENS JOHN CHARLES</creator><creator>NATCHUS MICHAEL GEORGE</creator><creator>BLASS BENJAMIN ERIC</creator><creator>TULLIS JOSHUA SPECTOR</creator><creator>DE BISWANATH</creator><creator>CLARK MICHAEL PHILIP</creator><scope>EVB</scope></search><sort><creationdate>20040616</creationdate><title>Triazole compounds useful in treating diseases associated with unwanted cytokine activity</title><author>VAN RENS JOHN CHARLES ; NATCHUS MICHAEL GEORGE ; BLASS BENJAMIN ERIC ; TULLIS JOSHUA SPECTOR ; DE BISWANATH ; CLARK MICHAEL PHILIP</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1505625A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VAN RENS JOHN CHARLES</creatorcontrib><creatorcontrib>NATCHUS MICHAEL GEORGE</creatorcontrib><creatorcontrib>BLASS BENJAMIN ERIC</creatorcontrib><creatorcontrib>TULLIS JOSHUA SPECTOR</creatorcontrib><creatorcontrib>DE BISWANATH</creatorcontrib><creatorcontrib>CLARK MICHAEL PHILIP</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VAN RENS JOHN CHARLES</au><au>NATCHUS MICHAEL GEORGE</au><au>BLASS BENJAMIN ERIC</au><au>TULLIS JOSHUA SPECTOR</au><au>DE BISWANATH</au><au>CLARK MICHAEL PHILIP</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Triazole compounds useful in treating diseases associated with unwanted cytokine activity</title><date>2004-06-16</date><risdate>2004</risdate><abstract>本发明涉及下式的4-芳基三唑:式(Ⅰ)其中每个R1独立地选自低级烷基、低级链烯基、低级炔基、低级杂烷基、低级杂烯基、低级杂炔基、杂环烷基、杂芳基、卤素、CN、OR4、SR4、S(O)R4、S(O)2R4和NR4R5;并且Q具有下式(Ⅱ):所述化合物能用于治疗与过度的细胞因子活性,尤其是与例如来自细胞的白介素-1(IL-1)和肿瘤坏死因子(TNF)有关的疾病。 The present invention relates to 4-aryl triazoles having the formula: wherein R1 is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR4, SR4, S(O)R4, S(O)2R4, and NR4R5; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN1505625A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Triazole compounds useful in treating diseases associated with unwanted cytokine activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A22%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VAN%20RENS%20JOHN%20CHARLES&rft.date=2004-06-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1505625A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true